RHEAUME; Eric

Patent Applications and Registrations

Patent applications and USPTO patent grants for RHEAUME; Eric.The latest application filed is for "methods for treating or preventing cardiovascular disorders and lowering risk of cardiovascular events".

Company Profile

0.0.11

RHEAUME; Eric - Montreal CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For Treating Or Preventing Cardiovascular Disorders And Lowering Risk Of Cardiovascular Events App 20210290623 - DUBE; Marie-Pierre ; et al.	2021-09-23
Methods For Treating Or Preventing Cardiovascular Disorders And Lowering Risk Of Cardiovascular Events App 20200222406 - DUBE; Marie-Pierre ; et al.	2020-07-16
A Co-culture System And Method For In Vitro Assessment Of Reverse Cholesterol Transport App 20190284527 - RHAINDS; David ; et al.	2019-09-19
Methods For Treating Or Preventing Cardiovascular Disorders And Lowering Risk Of Cardiovascular Events App 20190070178 - DUBE; Marie-Pierre ; et al.	2019-03-07
Pharmaceutical Compositions For The Treatment Of Left Ventricular Diastolic Dysfunction Comprising An Apolipoprotein Peptide/phospholipid Complex App 20150374675 - TARDIF; Jean-Claude ; et al.	2015-12-31
Pharmaceutical Compositions For The Treatment Of Left Ventricular Diastolic Dysfunction Comprising An Apolipoprotein Peptide/phospholipid Complex App 20140309426 - TARDIF; Jean-Claude ; et al.	2014-10-16
Pharmaceutical Compositions For The Treatment Of Left Ventricular Diastolic Dysfunction Comprising An Apolipoprotein Peptide/phospholipid Complex App 20130197226 - Tardif; Jean-Claude ; et al.	2013-08-01
Pharmaceutical Compositions For The Treatment Of Left Ventricular Diastolic Dysfunction App 20120021982 - Tardif; Jean-Claude ; et al.	2012-01-26
Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction App 20110288072 - Benatar; Vidal ; et al.	2011-11-24
Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction App 20080200450 - Benatar; Vidal ; et al.	2008-08-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.